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ABSTRACT
Rising opioid use in the United States has now been
termed an epidemic. Opioid use is associated with
considerable morbidity, mortality, and cost to the
healthcare system. Orthopaedic surgeons play a key
role in the opioid epidemic by prescribing postoperative
narcotics. Although our understanding of the quantity
of narcotics to prescribe postoperatively for analgesia
is progressing, there is still a paucity of data focused
on routine postoperative pain protocols. The purpose
of this article is to review the current options for both
opioid and non-opioid analgesia and put forth a multisubspecialty orthopaedic protocol of postoperative
pain. On the basis of study findings and the individual
experiences of surgeons within our orthopaedic
department, our comprehensive pain protocol includes
the following considerations: use of non-steroidal antiinflammatory drugs on an individual basis, limited use
of benzodiazepines, use of diazepam in only pediatric
patients undergoing major procedures, lower doses
of gabapentin after hip and knee arthroplasty, higher
doses of gabapentin after spine procedures, general
use of oxycodone owing to its accessibility, use of
isolated opioids rather than combined forms, and close
collaboration with anesthesiologists for determining use
of peripheral nerve block. Our resultant comprehensive
pain protocol can provide orthopaedic surgeons with a
framework to build upon, which will benefit greatly from
future studies that examine narcotic use with specific
procedures.
Keywords: Pain, Postoperative, Narcotic, Opioid,
Protocol

INTRODUCTION
Nociception is the mechanism by which tissue damage
is communicated from the periphery to the central
nervous system. The resulting pain has a large variability
and is defined as the unpleasant experience associated
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with a given stimulus.1 Pain is a common concern in
most fields of medicine, especially in orthopaedics. In
fact, treatment algorithms used in orthopaedics are
often guided by pain. Despite the common occurrence
of pain, little is understood about the variability and
postoperative treatment.
The increased availability of opioid medications
and the effort to adequately treat pain has led to
the dramatic rise of opioid use in the United States.2
Accordingly, opioid-related consequences have
increased. The United States represents about 4.4% of
the world’s population but consumes 80% of the global
opioid supply.3,4 The Centers for Disease Control and
Prevention estimates that 32,445 deaths occurred in
2016 due to prescription opioids, which is about 89
deaths per day.5 In comparison, 36,161 deaths occurred
due to motor vehicle accidents in 2015.6
It is estimated that orthopaedic surgeons prescribe
about 7% of prescription opioids in the United States.7
Additionally, orthopaedic surgeons prescribe more
opioids than most other specialty physicians owing
to the pain associated with common orthopaedic
procedures. Furthermore, orthopaedic surgeons often
prescribe more narcotics than patients use,8 which
can contribute to potential abuse and the diversion of
prescription narcotics to other uses and users.
The challenge of prescribing postoperative narcotic
medication is learning how to manage an amount
needed for pain control during an unpredictable time.
The goal is to find a balance in prescribing sufficient
quantities of narcotics, offsetting postoperative pain,
and minimizing potential risks of habituation and
inappropriate use. Finding a sufficient quantity is
dependent on multiple variables such as the surgical
procedure, operating time, preoperative opioid
exposure, use of non-narcotic agents, and patient
variability in pain perception.9 Although several of
these variables remain difficult to quantify, the typical
opioid quantity for a given surgical procedure appears

to be more predictable. The aim of this article is to
review frequently used postoperative pain regimens and
put forth a comprehensive protocol of postoperative
pain management that can be applied to common
orthopaedic procedures.

IMPLICATIONS OF A STANDARDIZED
PAIN PROTOCOL
Use of standardized protocols has become common
in medicine. Although protocols often evolve as the
studies expand, implementation of routine protocols
has proven effective in reducing patient morbidity
and mortality in multiple applications—ranging
from preoperative timeout10 to acute management
of unstable pelvic ring injuries.11 Despite emerging
reports of average amounts of opioids to prescribe
postoperatively, data are limited regarding the potential
benefits of prescribing a defined amount. Routine
protocols of postoperative pain management can
potentially improve morbidity and mortality and change
the landscape of the current opioid crisis.12,13

NON-STEROIDAL ANTI-INFLAMMATORY
DRUGS
Since the discovery of acetylsalicylic acid (ie, aspirin)
in the bark of a willow tree more than 70 years
ago, non-steroidal anti-inflammatory medications
(NSAIDs) have been used for analgesia.14 NSAIDs
inhibit cyclooxygenase 1 (COX-1) and 2 (COX-2) to
provide antipyretic, analgesic, anti-inflammatory, and
antithrombotic effets.15 Historically, the use of NSAIDs
in the management of orthopaedic injuries has been
controversial because of concerns of bleeding, delayed
wound healing, and fracture healing complication.15 In
children, however, NSAIDs have been shown to decrease
opioid consumption16,17 and are as effective as opioids in
reducing pain associated with uncomplicated fractures.18
Both the risks of NSAIDs and the benefits of decreased
opioid use favor the inclusion of NSAIDs in a multimodal
postoperative pain regimen.
Various NSAIDs are available, each one with a varying
duration of action, adverse effect profiles, analgesic
strength, and cost.19 Regarding orthopaedic surgical
procedures, no standard has been set on the “perfect”
NSAID, nor is there evidence that one NSAID regimen
is more effective for one procedure over another.
Therefore, the choice of NSAID should be left to the
discretion of the surgeon and patient, taking into
consideration the history of gastrointestinal bleed or
upset, cardiovascular history, renal health, allergies,
and associated anticoagulants. For this reason, our
institution’s orthopaedic department has agreed to use
NSAIDs on a case-by-case basis rather than universally
for every procedure.

OTHER NON-OPIOID MEDICATIONS
Acetaminophen, also known as paracetamol, is a
frequently employed and readily available analgesic
in the United States.20 Acetaminophen imparts its
antipyretic and analgesic effects to the central nervous

system; additionally, it regulates impact on the
inflammatory response.21 It is available in both oral and
intravenous forms, with intravenous typically reserved
for the immediate postoperative period when patients
may experience limited oral intake. Acetaminophen
has become a standard in our pain protocol because of
favorable adverse effect profile.
Gabapentin is a gamma-aminobutyric acid agonist
that acts primarily on spinal calcium channels, but
there are likely other pharmacodynamics that are not
understood.22 It has been well established that the role
of gabapentin is reducing phantom limb pain after
amputation23; however, the role of gabapentin as a
multimodal agent is less clear in other orthopaedic
procedures, particularly in arthroplasty.24-26 Two
randomized controlled trials that used gabapentin
postoperatively found slightly decreased opioid use
within the 48-hour period in one trial and no benefit
in the other.25,26 However, a meta-analysis by Han et
al27 found that gabapentin significantly reduced opioid
consumption within the first 24 and 48 hours after
surgery. The use of gabapentin has been shown to
be more effective in perioperative pain control after
lumbar spine procedures,28 however these data are
confounded by considerable preoperative use. As a
result of these mixed findings, we incorporated lowered
doses of gabapentin (300 mg every night) into our
routine postoperative pain protocol for hip and knee
arthroplasty. For patients recovering from a spine
procedure, we use a higher dose (ie, 600 mg every
night) because many of our patients were accustomed
to this medication preoperatively.
Benzodiazepines inhibit transmission on the
postsynaptic γ-aminobutyric acid (known as GABA)
neurons.29 Additionally, they act centrally on the spinal
cord and peripherally on muscle tissue to reduce
muscle spasms. The risk of respiratory depression with
opioids and benzodiazepines has been thoroughly
studied,30 and thus our use of this medication is quite
limited. In our protocol, diazepam is used solely in
treating children undergoing major procedures. In our
experience, this medication is typically used instead of
opioids for this specific population.

OPIOID MEDICATIONS
In the central nervous system, opioid medications
provide analgesia through their agonistic actions on the
Mu receptor; however, our understanding of the various
Mu receptors continues to evolve.31 Although opioids
may be effective for postoperative analgesia, their use
is not without drawbacks. Fletcher and Martinez32 linked
intraoperative exposure to opioids to hyperalgesia in
the immediate postoperative period, highlighting the
potential risks and early development of tolerance.
The association between duration of opioid use and
potential for misuse has also been well studied. Brat
et al12 found that with each refill, an additional week of
opioid use, the risk of misuse increased by 44%. The
many adverse effects of prolonged opioid exposure
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have been well described (eg, nausea, vomiting,
constipation, and respiratory depression).33 Thus,
the primary aim of our multimodal pain protocol was
to provide sufficient postoperative analgesia while
minimizing opioid use.
There are many available choices for oral opioid
analgesia. The options can be broadly categorized
into isolated versus combined forms, long versus
short acting, or by route of administration. For the
purpose of this review, we limited our discussion
to oral, short acting isolated, and combined forms.
Isolated forms include hydrocodone, oxycodone,
morphine, hydromorphone, methadone, among others.
Potency, duration of action, and half-life are unique
to each medication. To provide study uniformity
for the comparison of opioids, the use of milligram
morphine equivalents has become standard and is
readily available on the Centers for Disease Control
and Prevention website34; however, the accuracy of
conversion remains debatable.35,36 The isolated opioid
should be chosen by both the patient and provider
because the adverse effect profile and analgesic effect
are similar and dependent on dosage.37 Furthermore,
Basilico et al38 found no difference between the risk
of prolonged opioid use and prescription opioid type
after orthopaedic procedures. For the purposes of our
protocol, oxycodone is the most easily accessible and
readily available.
A few combined forms of opioid include oxycodone
and ibuprofen, oxycodone and acetaminophen, or
hydrocodone and acetaminophen.39 Many studies
have found no differences in the analgesic efficacy
of combined opioid and NSAID forms or opioid and
acetaminophen forms.40-43 Furthermore, when combining
opioid and NSAID medications, there is no evidence
of synergistic analgesic effect.44 Anecdotally, there
is a potential benefit of minimizing opioid overdose
in combined forms, which suggests that a patient
attempting to misuse or overdose oxycodone and
acetaminophen will reach toxic levels of acetaminophen
before respiratory depression. However, there is
no evidence to support this claim and we strongly
recommend that providers not rely on this method for
safety when prescribing opioids. Although combined
opioid forms may offer convenience, calculating safe
dosages of acetaminophen and NSAIDs to use in
conjunction can be burdensome and even dangerous
for patients. Therefore, the use of isolated opioids in our
protocol allows us to emphasize narcotic use solely as
needed after maximizing use of non-narcotic agents.
Additionally, it allows the patient to discontinue opioids
early in the postoperative period while continuing the
use of non-narcotics during recovery.
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REGIONAL ANESTHESIA
Regional anesthesia refers to the use of peripheral nerve
blocks for intraoperative and postoperative analgesia.
Additionally, it can be used in conjunction with general
anesthesia or monitored anesthesia care for a given
procedure. The safety of regional anesthesia has been
well established.45 Furthermore, regional anesthesia has
been shown to significantly reduce opioid consumption
in arthroplasty, fracture treatment, and arthroscopy.46-49
Although the use of peripheral nerve blocks has been
widely adopted into our practice as orthopaedic
surgeons, collaboration with anesthesiologists is
crucial. Peripheral nerve block locations, medications,
and dosages continue to change. Because of this, we
defer their use to our anesthesia colleagues rather
than implement them into a uniform and standardized
protocol. Although the choice of peripheral nerve block
may vary between cases, our anesthesia colleagues
typically provide interscalene blocks for shoulder
procedures; infraclavicular blocks for elbow, wrist,
and hand procedures; combined femoral and sciatic
blocks for arthroscopic knee procedures; popliteal and
saphenous blocks for foot and ankle procedures; and
spinal anesthesia for hip and knee arthroplasty.

CONCLUSION
To address the lack of a standardized pain protocol,
surgeons of our orthopaedic department synthesized
their individual protocols, with gaps subsidized by
agreeable surgeon-specific preferences. In Appendices
1 through 7, we present the resultant comprehensive
postoperative pain protocol. The purpose of the
protocol is to maximize non-narcotic analgesia and
provide a standard quantity of opioid for various
orthopaedic procedures.
Notably, the protocol focuses on common procedures
and does not address every possible procedure that
an orthopaedic surgeon could perform. However,
it can be applied as a framework for less common
procedures. Within the protocol, some procedures are
identified as major or minor depending on the severity
of the treatment and anticipated postoperative pain
experienced. Furthermore, we expect deviations from
the protocol in cases of patient allergies, prior opioid
exposure, and preoperative medications.
Early results of implementing a standard pain
protocol are encouraging but limited to single
subspecialties.13 To our knowledge, this is the first
review to put forth a multi-subspecialty protocol.
Studies evaluating the benefits of a multi-subspecialty
protocol are currently underway, and future work
dedicated to minimizing narcotic use remain paramount.
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Appendix 1. Postoperative protocol for managing pain after common foot and ankle procedures
Drug

ORIF for Ankle Injuries

Bunion Surgery

Acetaminophen
Quantity
Durationa

80 tablets (500 mg)
2 every 8 h

80 tablets (500 mg)
2 every 8 h

Ibuprofen
Quantity
Duration

40 tablets (800 mg)
1 TID as needed

40 tablets (800 mg)
1 TID as needed

Oxycodoneb
Quantity
Duration

30 tablets (5 mg)
1 every 6 h as needed

20 tablets (5 mg)
1 every 6 h as needed

TID, three times a day.
a
Patients should take this until pain resolves.
b
Patients should take for breakthrough pain.

Appendix 2. Postoperative protocol for managing pain after common hand procedures
Drug

Trigger finger
release

Carpal tunnel
release

De Quervain’s
release

ORIF for DR
fractures

Acetaminophen
Quantity
Durationa

80 tablets (500 mg)
2 every 8 h

“
“

“
“

“
“

Ibuprofen
Quantity
Duration

40 tablets (800 mg)
1 TID as needed

“
“

“
“

“
“

Oxycodone
Quantity
Durationb

5 tablets (5 mg)
1 every 6 h as needed

“
“

“
“

15 tablets (5 mg)
“

TID, three times a day; “, same information as in the row to the left; ORIF, open reduction and internal fixation; DR, distal radius.
a
Patients should take this until pain resolves.
b
Patients should take for breakthrough pain.
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Appendix 3. Postoperative protocol for managing pain after common pediatric procedures and conditionsa,b
Drug

Minor proceduresc

Major proceduresd

Scoliosis

Hycete
Quantity
Duration

0.1 mg/kg
Every 6 h for 5 days

0.1 mg/kg
Every 6 h for 14 days

0.1 mg/kg
Every 6 h for 14 days

Ibuprofen
Quantity
Duration

10 mg/kg
every 6 h for 5 days

10 mg/kg
Every 6 h for 14 days

---

Diazepam
Quantity
Duration

---

5 mg/5 mL (0.1 mg/kg)
Every 6 h for 7 daysf

5 mg/5mL (0.1 mg/kg)
Every 6 h for 7 daysf

Senna
Quantity
Duration

8.8 mg/5mL
Oral syrup for 5 days

8.8 mg/5 mL
Oral syrup for 14 days

8.8 mg/5 mL
Oral syrup for 14 days

Gabapentin
Quantity
Duration

---

---

300 mg
Every evening for 14 days

Miralax
Quantity
Duration

---

---

17 g
Every day for 7 days (225 g)i

Ibuprofen
Quantity
Duration

10 mg/kg
Every 6 h for 5 days

10 mg/kg
Every 6 h for 14 days

---

Tylenol
Quantity
Duration

10 mg/kg
Every 4 h for 5 days

10 mg/kg
Every 4 h for 14 days

10 mg/kg
Every 4 h for 14 days

Oxycodone
Quantity
Duration

0.1 mg/kg
Every 4 h for 5 days

0.1 mg/kg
Every 4 h for 7 daysg

0.1 mg/kg
Every 4 hours for 7 daysg

Diazepam
Quantity
Duration

---

5 mg/5 mL (0.1 mg/kg)
Every 6 hh

5 mg/5 mL (0.1 mg/kg)
Every 6 hh

Docusate
Quantity
Duration

50 mg
BID for 5 days

50 mg
BID for 14 days

---

Senna
Quantity
Duration

---

---

8.8 mg /5 mL
Oral syrup for 14 days

Gabapentin
Quantity
Duration

---

---

300 mg
Every evening for 14 days

Miralax
Quantity
Duration

---

---

17 g
Every day for 7 days (255 g)i

Liquids

Pills

--, not applicable; BID, twice a day.
a
For infants < 1 year: use hycet (7.5 mg hydrocodone / 325 mg paracetamol in 15 mL) 0.1mg/kg every 6 h for 5 days. Solution comes in
concentration as above, so typically give 2 mL for a 10 kg baby.
b
Consider a daily aspirin 325 mg for 28 days for all adolescent females, especially those on birth control.
c
Examples of minor procedures are as follows: tendon-Achilles lengthening, surgical fixation of supracondylar fractures, epiphysiodesis,
tendon transfers, hardware removal, etc.
d
Examples of major procedures are as follows: acetabular and femoral osteotomies, surgical fixation of femur and tibia fractures, calcaneal
osteotomies, etc.
e
Hydrocodone or paracetamol.
f
For muscle spasms.
g
Do not exceed 60 tablets.
h
For muscle spasms; do not exceed 30 tablets.
i
Tirate to soft stools.
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Appendix 4. Postoperative protocol for managing pain after common spine procedures
Drug

Inpatient management plana

Gabapentin
Quantity
Duration

600 mg
QHS

Acetaminophen
Quantity
Duration

1000 mg (≤ 4000 mg)
Every 6 h

Ketorolacb
Quantity
Duration

30 mg (≤ 210 mg)
Every 6 h for first 24 h

Ibuprofenb
Quantity
Duration

800 mg (≤ 3200 mg)
Every 6 h as needed after first 24 h

Dexamethasonec
Quantity
Duration

8 mg
PO daily for 48 h

Methocarbamol
Quantity
Duration

500 mg (≤ 4000 mg)
QID as needed for muscle spasm

Opioids after inpatient management plan medications are maxed outd
Oxycodone
Quantity
Duration

5 mg
Every 4 h as needed for pain

Oxycodone
Quantity
Duration

10 mg
Every 4 h as needed for pain

Morphine
Quantity
Duration

2-4 mg
Every 4 h as needed for pain

Dilaudid
Quantity
Duration

0.5-2 mg
Every 4 h as needed

Bowel regimen
Senna
Quantity
Duration

-BID

Miralax
Quantity
Duration

17 g
Powder BID if no bowel movement by postoperative day 3

Discharge medication (until 2 weeks postoperatively)
Gabapentin
Quantity
Duration

600 mg (28 300 mg tablets)
QHS

Acetaminophen
Quantity
Duration

1000 mg (56 tablets)
Every 6 h (≤ 4000 mg daily)

Meloxicam
Quantity
Duration

7.5 mg (14 tablets)
Every day as needed

Oxycodone
Quantity
Duration

5 mg (80 tablets)
Every 4 h as needed

Senna
Quantity
Duration

28 tablets
1 tablet BID while continuing opioid use

Promethazine
Quantity
Duration

12.5 mg (30 tablets)
Every 6 h as needed for nausea

QHS, every night before bed; PO, orally; QID, for times a day; --, not applicable; BID, twice a day.
a
Applied to both elective and trauma patients unless contraindicated. If previous opioid use is greater than 120 morphine equivalents (ie, 80
mg of oxycodone) per day, defer to consultation with inpatient pain management service.
b
Becuase this is a nonsteroidal anti-inflammatory drug, it should be avoided if there is concern for poor bone healing. Give with proton pump
inhibitors (ie, PPI) or H2 receptor blockers.
c
Avoid if concern for poor wound healing.
d
For continuous opioids, avoid basal rates—to be used in low dose for breakthrough pain in the immediate postoperative period.
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Appendix 5. Postoperative protocol for managing pain after total joint arthroplasty
Drug

Inpatient management plan

Toradol
Quantity
Duration

15 mg
IV Every 6 h for 48 h (hold for h/o GI bleed or GFR < 60)

Meloxicama
Quantity
Duration

7.5 mg
PO every day for remainder of stay

Tylenol
Quantity
Duration

1g
PO every 8 h (hold for hepatitis C)

Decadron
Quantity
Duration

4 mg
IV every day for 2 days (hold for diabetes)

Gabapentin
Quantity
Duration

300 mg
PO QHS

Famotidine
Quantity
Duration

20 mg
BID
For patients aged < 70 years

Oxycontin
Quantity
Duration

10 mg
PO BID (monitor closely in OSA)

Oxycodone
Quantity
Duration

5 mg
PO every 4 h as needed for moderate pain

Oxycodone
Quantity
Duration

10 mg
PO every 4 h as needed for severe pain

Morphine
Quantity
Duration

2 mg
IV every 4 h as needed for intractable pain only
For patients aged > 70 years (hold oxycontin)

Oxycodone
Quantity
Duration

5 mg
PO every 4 h (monitor closely for AMS and delirium)

Tramadol
Quantity
Duration

50 mg
PO every 6 h as needed for moderate pain

Oxycodone
Quantity
Duration

5 mg
PO every 4 h as needed for moderate pain

Morphine
Quantity
Duration

2 mg
IV every 4 h as needed for intractable pain only
Outpatient management plan

Aspirin
Quantity
Duration

81 mg (30 tablets)
BID (vs Lovenox) for 30 days

Meloxicam
Quantity
Duration

7.5 mg (30 tablets)
PO daily for 30 days

Gabapentin
Quantity
Duration

300 mg (30 tablets)
PO QHS for 30 days

Famotidine
Quantity
Duration

20 mg (30 tablets)
PO daily for 30 days

Continued on the next page
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Tylenol
Quantity
Duration

1g
PO TID for 2 weeks, then as needed for up to 6 weeks

Zofran
Quantity
Duration

4 mg (10 tablets)
PO every 6 h daily for 2 weeks

Docusate
Quantity
Duration

100 mg (28 tablets)
PO BID for 2 weeks
For patients aged < 70 yearsb,c

Oxycodone
Quantity
Duration

5 mg (60 tablets)
PO 1-2 tablets every 4-6 h as needed for 2 weeks

Oxycodone
Quantity
Duration

5 mg (30 tablets)
PO 1 tablet every 6 h (from 2 to 6 weeks)

GFR, glomerular filtration rate; GI, gastrointestinal; QHS, every night before bed; BID, twice a day; IV, intravenous; PO, orally; OSA, obstructive
sleep apnea; AMS, altered mental status; TID, twice a day.
a
Take after toradol.
b
No narcotics beyond 6 weeks, switch to tramadol if as-needed medication is still required.
c
For patients aged > 70 years, consider oxycodone if well tolerated while in-house and high pain level, or tramadol (50 mg, 60 tablets) at 1
tablet orally every 6 h.

Appendix 6. Postoperative protocol for managing pain after trauma-related procedures
Drug

Minor proceduresa

Major proceduresb

500 mg
BID 1 tablet every 12 h for 3 days then BID
(Disp #30 refill 2)c

“
“

325 mg
2 tablets every 6 h for 3 days then 1-2 tablets
every 6 h (Disp #60 refill 2)c

“
“

Oxycodone
Quantity
Duration

5 mg
1 tablet every 6 h (Disp #10)c

“
1 tablet every 6 h (Disp #30)c

Lovenox
Quantity
Duration

---

40 mg
Daily for 2 weeks followed by aspirin

Aspirin
Quantity
Duration

81 mg
BID for 4 weeks (Disp #14)

“
“ to follow lovenox

Zofran
Quantity
Duration

4 mg
Every 8 h (Disp #5 refill 1)d

“
“

Docusate
Quantity
Duration

100 mg
Daily for 14 days (Disp #14 refill 1)

“
“

Gabapentin
Quantity
Duration

---

300 mg
Every evening for 14 days for amputations

Naprosyn
Quantity
Duration
Tylenol
Quantity
Duration

“, same information as in the row to the left; BID, twice a day; Disp, dispense; --, not applicable.
a
Minor procedures include debridement, surgical treatment of flexor tenosynovitis, surgical fixation of finger fractures, etc.
b
Major procedures include surgical fixation of ankle, tibial plateau, acetabular, patella, both bone, and distal radius fractures as well as
amputations, etc.
c
As needed for pain.
d
As needed for nausea.
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Appendix 7. Postoperative protocol for managing pain after sports medicine proceduresa
Drug
Naprosyn
Quantity
Duration

Tylenol
Quantity
Duration

Oxycodone
Quantity
Duration

Minor proceduresb

Major proceduresc

Hip scope

Shoulder arthroplasty

500 mg
1 tablet every 12 h for 3
days then BIDd (Disp #30
refill 2)

“
“

“
1 tablet every 12 h for
30 days (Disp #60
refill 2)

“
1 tablet every 12 h for
3 days then BIDd (Disp
#30 refill 2)

325 mg
2 tablets every 6 h for 3
days then 1-2 tablets every
6 hd (Disp #60 refill 2)

“
“

“
“

“
“

5 mg
1 tablet every 6 hd (Disp
#30)

5 mg
1 tablet every 6 hd
(Disp #10)

“
1 tablet every 6 hd
(Disp #30)

“
“

Aspirin
Quantity
Duration

81 mg
“
BID for 2 weeks (Disp #28) “

325 mg
“
QD for 4 weeks (Disp OD for 4 weeks (Disp
#5 refill 1)
#28)

Zofran
Quantity
Duration

4 mg
Every 8 he (Disp #5 refill 1)

“
“

“
“

“
“

“, same information as in the row to the left; BID, twice a day; Disp, dispense; --, not applicable; QD, once a day.
a
Please use this for all patients undergoing treatment with sports medicine attendings unless directed otherwise by the attending, or if a
contraindication is identified for an individual patient.
b
Minor procedures include debridement, non-implant procedures, minimal to no bone work, and implant removal.
c
Major procedures include those that require use of implants.
d
As needed for pain.
e
As needed for nausea.
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